Dallas
214-456-2382
Fax: 214-456-6133
Plano
469-303-4400
Fax: 469-303-4420
Referrals
Request an Appointment with codes: Cancer and Blood Disorders (CCBD)
Pediatric medulloblastoma (me·dul·lo·blas·to·ma) is a type of tumor that typically starts in the brain and can spread elsewhere in the brain and spinal cord. Children’s Health℠ offers state-of-the-art therapies to treat these cancers and a team of physicians – on the faculty at UT Southwestern Medical School – who work together to give your child the best opportunity to get back to normal childhood.
214-456-2382
Fax: 214-456-6133
469-303-4400
Fax: 469-303-4420
Request an Appointment with codes: Cancer and Blood Disorders (CCBD)
Medulloblastoma develops from cells in the brain that are believed to be primitive nerve cells.
Medulloblastoma is the most common malignant brain tumor in children and only rarely affects adults.
Each year, around 600 children in the U.S. are diagnosed with this tumor. They are commonly diagnosed in children between the ages of 1 and 10 years.
Medulloblastomas can press into the brain or spinal cord, which can affect your child’s ability to think, move and do other tasks. These tumors can cause symptoms such as:
The exact cause of medulloblastoma in most children is not known. Some children with medulloblastomas have a “genetic predisposition,” which means their genes put them at higher risk of developing this and related cancers. Since families share many of the same genes, other family members may also be at higher risk of certain cancers. If a genetic predisposition to cancer is found, we may recommend that parents and siblings have genetic testing.
We adjust our approach depending on your child’s age and their type of tumor. Treatments may include:
We offer care from doctors and other specialists who focus specifically on brain tumors. Physicians practicing at Children’s Health are also on the faculty at UT Southwestern Medical Center and have seen more children with medulloblastoma than almost any other center in the region. Our experience and teamwork help us act quickly to treat your child’s cancer and reduce their pain and symptoms.
The survival rate is around 85% for children with medulloblastoma that hasn’t spread to other parts of their body. The rate is lower in cases where the cancer spreads.
We do. Proton therapy kills cancer cells by shooting high-energy particles (called protons) directly at the tumor. This often causes fewer side effects than other radiation therapy, which uses X-rays. It can also have fewer side effects than chemotherapy, which sends chemicals throughout the whole body.